Contact
Please use this form to send email to PR contact of this press release:
Algernon Pharmaceuticals to Conduct Phase 1 DMT Stroke Program Study with Hammersmith Medicines Research (UK)
TO:
Please use this form to send email to PR contact of this press release:
Algernon Pharmaceuticals to Conduct Phase 1 DMT Stroke Program Study with Hammersmith Medicines Research (UK)
TO: